| Basics |
|
Apogee Therapeutics, Inc.
|
| IPO Date: |
July 14, 2023 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$3.85B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.10 | 2.83%
|
| Avg Daily Range (30 D): |
$1.11 | 2.50%
|
| Avg Daily Range (90 D): |
$1.05 | 2.51%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.44M |
| Avg Daily Volume (30 D): |
.58M |
| Avg Daily Volume (90 D): |
.64M |
| Trade Size |
| Avg Trade Size (Sh.): |
55 |
| Avg Trade Size (Sh.) (30 D): |
49 |
| Avg Trade Size (Sh.) (90 D): |
51 |
| Institutional Trades |
| Total Inst.Trades: |
1,165 |
| Avg Inst. Trade: |
$2.72M |
| Avg Inst. Trade (30 D): |
$3.67M |
| Avg Inst. Trade (90 D): |
$2.67M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.96M |
| Avg Closing Trade (30 D): |
$7.04M |
| Avg Closing Trade (90 D): |
$5.07M |
| Avg Closing Volume: |
92.29K |
|
|
| News |
Oct 10, 2025 @ 8:01 PM
Apogee Therapeutics, Inc. Announces Closing of Pub...
Source: Apogee Therapeutics, Inc.
|
Oct 9, 2025 @ 9:26 PM
Why Apogee Therapeutics Stock Triumphed on Thursda...
Source: Eric Volkman
|
Oct 9, 2025 @ 1:52 AM
Apogee Therapeutics, Inc. Announces Pricing of $30...
Source: Apogee Therapeutics, Inc.
|
Jul 7, 2025 @ 10:00 AM
Apogee Therapeutics Announces Positive 16-Week Dat...
Source: Apogee Therapeutics
|
Jul 6, 2025 @ 10:00 PM
Apogee Therapeutics to Host Conference Call to Rep...
Source: Apogee Therapeutics, Inc.
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
$-1.13
|
$-.95
|
$-.86
|
|
Diluted EPS
|
$-1.13
|
$-.95
|
$-.86
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -66.1M
|
$ -55.34M
|
$ -49.02M
|
|
Operating Income / Loss
|
$ -73.17M
|
$ -63.1M
|
$ -58.69M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 17.28M
|
$ -34.87M
|
$ -188.52M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 08, 2008:
1:50
|
|
|
|
